We are live on ! Find out more
TCM

Tyro Capital Management Portfolio holdings

AUM $446M
1-Year Est. Return 84.15%
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
+84.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$269M
AUM Growth
+$14.3M
Cap. Flow
+$27.2M
Cap. Flow %
10.1%
Top 10 Hldgs %
100%
Holding
12
New
2
Increased
8
Reduced
Closed
2

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$20.3M
2
LQDA icon
Liquidia Corp
LQDA
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.97%
2 Communication Services 22.79%
3 Industrials 19.28%
4 Consumer Discretionary 17.91%
5 Materials 16.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTA icon
1
Establishment Labs
ESTA
$2.13B
$44.2M 16.41%
1,077,456
+10,735
+1% +$439K
CRH icon
2
CRH
CRH
$61.9B
$43.2M 16.06%
360,495
+22,935
+7% +$2.42M
CCOI icon
3
Cogent Communications
CCOI
$513M
$35.9M 13.32%
935,287
+298,392
+47% +$12.5M
CRS icon
4
Carpenter Technology
CRS
$24.2B
$31M 11.52%
126,250
+48,576
+63% +$12.4M
GRPN icon
5
Groupon
GRPN
$797M
$25.5M 9.46%
1,091,095
+69,378
+7% +$2M
CROX icon
6
Crocs
CROX
$6.03B
$24.2M 9%
290,008
+108,986
+60% +$9.95M
SN icon
7
SharkNinja
SN
$25.4B
$24M 8.91%
232,602
+14,799
+7% +$1.69M
ROAD icon
8
Construction Partners
ROAD
$6.42B
$20.9M 7.76%
164,488
+10,465
+7% +$1.19M
HNGE
9
Hinge Health
HNGE
$6.91B
$15.7M 5.82%
+319,076
New +$16.7M
LENZ
10
LENZ Therapeutics
LENZ
$146M
$4.69M 1.74%
+100,672
New +$3.7M
LQDA icon
11
Liquidia Corp
LQDA
$6.36B
-1,241,839
Closed -$15.5M
VRNA
12
DELISTED
Verona Pharma
VRNA
-214,719
Closed -$20.3M

Similar funds

Tyro Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Tyro Capital Management held 12 positions worth $269M, up 5.6% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyro Capital Management deployed $27.2M of net new capital in Q3 2025, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was Hinge Health: 319,076 shares worth $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 32% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the most notable exit was Verona Pharma, an estimated $20.3M sold.

  • Tyro Capital Management's largest Q3 2025 buy was Hinge Health: 319,076 shares worth $15.7M.
  • Tyro Capital Management added most to Cogent Communications in Q3 2025, an estimated $12.5M increase.
  • Tyro Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $20.3M.
  • Tyro Capital Management's ten largest holdings make up 100% of its $269M portfolio in Q3 2025.
  • Tyro Capital Management opened 2 new positions and closed 2 in Q3 2025.
  • Tyro Capital Management's portfolio value rose 5.6% quarter-over-quarter to $269M.

Based on Tyro Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.